The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features-Reference-Cited by-同舟云学术

The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

Published:2015-11-25 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Aloia Andrea,Petrova Evgeniya,Tomiuk Stefan,Bissels Ute,Déas Olivier,Saini Massimo,Zickgraf Franziska Maria,Wagner Steve,Spaich Saskia,Sütterlin Marc,Schneeweiss Andreas,Reitberger Manuel,Rüberg Silvia,Gerstmayer Bernhard,Agorku David,Knöbel Sebastian,Terranegra Annalisa,Falleni Monica,Soldati Laura,Sprick Martin Ronald,Trumpp Andreas,Judde Jean-Gabriel,Bosio Andreas,Cairo Stefano,Hardt Olaf

Funder

Seventh Framework Programme

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0652-6.pdf

Reference40 articles.

1. Rivenbark AG, O’Connor SM, Coleman WB. Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine. Am J Pathol. 2013;183(4):1113–24.

2. Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, et al. Luminal B breast cancer: molecular characterization, clinical management, and future perspectives. J Clin Oncol. 2014;32(25):2794–803.

3. Irvin Jr WJ, Carey LA. What is triple-negative breast cancer? Eur J Cancer. 2008;44(18):2799–805.

4. Davis SL, Eckhardt SG, Tentler JJ, Diamond JR. Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers. Ther Adv Med Oncol. 2014;6(3):88–100.

5. Liedtke C, Mazouni C, Hess KR, Andre F, Tordai A, Mejia JA, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275–81.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of genetically determined circulating proteins with breast cancer risk or survival;2024-01-31

2. Increased expression of SSEA-4 on TKI-resistant non–small cell lung cancer with EGFR-T790M mutation;Proceedings of the National Academy of Sciences;2024-01-22

3. Therapeutic targeting of aberrant sialylation for prevention of chemoresistance and metastasis in triple negative breast cancer;Journal of Drug Delivery Science and Technology;2023-09

4. Intact glycopeptides identified by LC-MS/MS as biomarkers for response to chemotherapy of locally advanced cervical cancer;Frontiers in Oncology;2023-07-13

5. Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases;Progress in Lipid Research;2023-07